CREDIT SUISSE AG/ - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 45 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$333,8750.0%360,0000.0%0.00%
Q1 2023$333,875
-84.9%
360,000
-84.7%
0.00%
-100.0%
Q3 2022$2,216,000
+24522.2%
2,350,000
+23400.0%
0.00%
Q2 2022$9,000
-35.7%
10,000
-33.3%
0.00%
Q3 2021$14,000
-99.7%
15,000
-99.7%
0.00%
-100.0%
Q2 2021$4,385,000
+974.8%
4,761,000
+1090.2%
0.00%
Q4 2020$408,000400,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Opti Capital Management, LP 42,313,000$39,204,3063.17%
DeepCurrents Investment Group LLC 76,898,000$70,957,7072.76%
Penn Mutual Asset Management 2,756,000$2,537,0972.41%
TENOR CAPITAL MANAGEMENT Co., L.P. 129,852,000$120,146,0012.39%
Sonora Investment Management Group, LLC 18,930,000$17,542,9621.53%
DLD Asset Management, LP 15,000,000$13,968,7501.18%
BRAIDWELL LP 36,533,000$33,800,4771.12%
Worth Venture Partners, LLC 1,455,000$1,349,1490.66%
Verition Fund Management LLC 22,266$20,600,5920.28%
III Capital Management 5,100,000$4,712,0600.26%
View complete list of IONIS PHARMACEUTICALS INC shareholders